Adventum has been acquired by Humana
August 2012 — Humana, a leading Swedish provider of personal assistance services, has acquired Adventum, a specialized care provider offering support and care for children with social and psychiatric problems. Financial terms of this transaction have not been disclosed.
Humana is focused on elderly care, individual and family care, residential arrangements offering support and services for persons with certain functional impairments, as well as schools for students with disabilities.
This acquisition is an important step for Humana in developing its business unit Individual and Family that includes Baggium Care and Treatment, Tian Group and K REHAB. Adventum is a fast-growing, high quality company in an exciting market that is in the initial consolidation phase.
Our role in the transaction
Oaklins' team in Sweden advised the seller in this transaction.
Talk to the deal team
Related deals
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreAsana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.
Learn moreLaboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors
Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners alongside co-investors Ouest Croissance, Sodero and CE IDF, with Bpifrance, Océans Participations and the management team reinvesting.
Learn more